share_log

Piper Sandler Maintains Overweight on Gritstone Bio, Raises Price Target to $7

Benzinga ·  Sep 28, 2023 07:53

Piper Sandler analyst Edward Tenthoff maintains Gritstone Bio (NASDAQ:GRTS) with a Overweight and raises the price target from $6 to $7.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment